An official website of the United States government
A Stress Management and Resiliency Training Intervention for Improving Quality of Life, Resilience, and Stress Management in Lymphoma Survivors
Trial Status: active
This clinical trial evaluates whether a resilience intervention called Stress Management and Resiliency Training: Relaxation Response Resiliency-Lymphoma (SMART3RP-Lymphoma) is more effective than a general health education program for improving quality of life, resilience, and stress management in lymphoma survivors. SMART3RP-Lymphoma is an evidence-based, multimodal, mind-body group program shown to improve resiliency by teaching skills drawn from mind-body, cognitive behavioral, and positive psychology theory. SMART3RP-Lymphoma may be more effective than a general health education program for improving quality of life, resilience, and stress management in lymphoma survivors.
Inclusion Criteria
English or Spanish speaking adult (18 years or older at enrollment)
Within 1-5 years of completing active treatment for lymphoma (includes surgery, chemotherapy/immunotherapy/radiation therapy, or other); survivors may be on maintenance therapy
Access to an internet-connected device with video
Exclusion Criteria
Active psychiatric or cognitive comorbidity as determined by site principal investigator (PI) or treating clinician
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07013435.
Locations matching your search criteria
United States
Florida
Miami
University of Miami Miller School of Medicine-Sylvester Cancer Center
I. To assess the effects of SMART3RP-Lymphoma versus (vs.) health education program (HEP) on quality of life.
II. To examine if changes in resilience contribute to quality of life improvements.
III. To examine early implementation processes.
IV. To examine the impact of the intervention on cortisol.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients attend 8 SMART3RP-lymphoma group sessions weekly, over 90 minutes each, that cover stress management and resiliency training, relaxation response, stress awareness, mending mind and body, creating an adaptive perspective, promoting positivity, healing states of mind, and humor and staying resilient. After each group session, patients receive a link with a corresponding relaxation response technique to practice.
ARM II: Patients attend 8 health education program group sessions weekly, over 90 minutes each, that cover education on the co-occurrence of mental and physical problems, goal setting for health behavior change, and self-monitoring.
After completion of study intervention, patients are followed up at 3, 6, and 12 months.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationDana-Farber Harvard Cancer Center
